|
⚲
|
| Keyboard |
| Mark Leuchtenberger | |
|---|---|
| Firm | |
| Address | 11 Hamenofim Street, Building B Herzliya, L3 4672562 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Neurosense Therapeutics Ltd | 021-531943 | Director | 5.0 M of 5.0 M |
||
| Neurosense Therapeutics Ltd | 021-511619 | Director | 4.5 M of 4.5 M |
||
| Neurosense Therapeutics Ltd | 021-485926 | Director | 4.5 M of 4.5 M |
||
| Aleta Biotherapeutics Inc | 021-406597 | Executive Officer | 13.7 M | ||
| IRX Therapeutics Inc | 021-278212 | Executive Officer | 33.2 M of 33.2 M |
||
| Rib-X Pharmaceuticals Inc | 021-187690 | Executive Officer | 18.7 M of 67.5 M |
||
| Rib X Pharmaceuticals Inc | 021-154520 | Executive Officer | 5.5 M of 22.0 M |
||
| Mercator Therapeutics Inc | 021-146121 | Director | 2.0 M of 2.0 M |
||
| Rib X Pharmaceuticals Inc | 021-143283 | Executive Officer | 5.5 M of 15.0 M |
||